In summary, we identified for the first time that SCNN1B acts as a tumor suppressor in CRC by targeting of MAPK oncogenic signaling through inactivation of c-Raf, thus impairing MEK-ERK signaling cascades. Here, RAF1 is linked to neoplasm.